APA (7th ed.) Citation

J, K., M, L., C, W., UB, K., S, D., KA, A., . . . A, Z. (2025). Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial. Nature communications, 16(1), 4558. https://doi.org/10.1038/s41467-025-59739-6

Chicago Style (17th ed.) Citation

J, Khong, et al. "Tacrolimus Dosing in Liver Transplant Recipients Using Phenotypic Personalized Medicine: A Phase 2 Randomized Clinical Trial." Nature Communications 16, no. 1 (2025): 4558. https://doi.org/10.1038/s41467-025-59739-6.

MLA (9th ed.) Citation

J, Khong, et al. "Tacrolimus Dosing in Liver Transplant Recipients Using Phenotypic Personalized Medicine: A Phase 2 Randomized Clinical Trial." Nature Communications, vol. 16, no. 1, 2025, p. 4558, https://doi.org/10.1038/s41467-025-59739-6.